24The myometrium undergoes structural and functional remodeling during pregnancy. We 25 hypothesize that myometrial genomic elements alter correspondingly in preparation for 26 parturition. Human myometrial tissues from nonpregnant (NP) and term pregnant (TP) human 27 subjects were examined by RNAseq, ATAC-seq and PGR ChIP-seq assays to profile 28 transcriptome, assessible genome and PGR occupancy. NP and TP specimens exhibit 2890 29 differentially expressed genes, reflecting an increase of metabolic, inflammatory and PDGF 30 signaling, among others, in adaptation to pregnancy. At the epigenome level, patterns of 31 accessible genome change between NP and TP myometrium, leading to altered enrichment of 32 binding motifs for hormone and muscle regulators such as the progesterone receptor (PGR),
33Krüppel-like factors and MEF2A transcription factors. PGR genome occupancy exhibits a 34 significant difference between the two stages of the myometrium, concomitant with distinct 35 transcriptomic profiles including genes such as ENO1, LHDA, and PLCL1 in the glycolytic and 36 calcium signaling pathways. Over-representation of SRF, MYOD and STAT binding motifs in 37 PGR occupying sites further suggests interactions between PGR and major muscle regulators for 38 myometrial gene expression. In conclusion, changes in accessible genome and PGR occupancy 39 are part of the myometrial remodeling process and may serve as mechanisms to formulate the 40 state-specific transcriptome profiles. 41 pregnancy had been complicated by other medical conditions (including but not limited to 101 gestational diabetes >IB, chorioamnionitis, pregnancy-induced hypertension, preeclampsia, 102 HELLP syndrome or its variants). Specimens of non-gravid myometrium (NP) were obtained 103 from healthy, pre-menopausal women undergoing routine, clinically-indicated gynecologic 104 surgery. All non-gravid myometrial specimens were collected from healthy myometrium at sites 105 that excluded both the uterine serosa and endometrium and were at least 2 cm from the nearest 106 leiomyoma. Any specimens from women using progestins prior to their surgery were excluded 107 from analysis.
108After washing each specimen briefly in phosphate buffered saline (PBS), pieces of myometrium 109 were either flash frozen (ChIP-Seq) or preserved by plunging them into ice-cold RNALater 110 (RNA-Seq) with warm ischemia time less than 30 minutes. All specimens weresubsequently 111 stored at <-80°C until use. Assays for each individual sample are listed in Table S1. 112 RNA Extraction 113 Myometrial specimens were homogenized by the bead Mill 24 homogenizer (15-340-163, Fisher 114 Scientific, Waltham, MA) in Bead Mill Tubes (15-340-154 Fisher Scientific, Waltham, MA) 115 with 1 mL Trizol (15596026, Thermo Fisher Scientific, Waltham, MA). Tissue debris was 116 pelleted and removed by centrifugation at 12000 xg for 10 minutes at 4°C. After adding 200 uL 117 1-Bromo-3-chloropropane, samples were manually shake for 20 seconds followed by incubation 118 at room temperature for 3 minu...